AMS
AMERICAN SHARED HOSPITAL SERVICES
Company overview
- Market capitalization
- $9.51M
- Employees
- 82
- Latest publication
- 2026-09-29
About AMERICAN SHARED HOSPITAL SERVICES
American Shared Hospital Services provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. It operates in two segments: Leasing and Direct Patient Service. The company leases nine Gamma Knife systems and one proton beam radiation therapy (PBRT) system; and provides planning, installation, reimbursement, and marketing support services. It also owns and operates two single-unit Gamma Knife facilities that provides radiosurgery services directly to the patient. The company markets its solutions to cancer treatment centers, health systems, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 8,430,000USD | 7,084,000USD | 7,728,000USD | 7,171,000USD | 7,071,000USD | 6,112,000USD | 9,069,000USD | 6,999,000USD |
| Cost Of Revenue | 6,997,000USD | 5,796,000USD | 6,822,000USD | 5,598,000USD | 5,452,000USD | 5,174,000USD | 5,865,000USD | 5,629,000USD |
| Gross Profit | 1,433,000USD | 1,288,000USD | 906,000USD | 1,573,000USD | 1,619,000USD | 938,000USD | 3,204,000USD | 1,370,000USD |
| Selling General Administrative | 2,042,000USD | 1,910,000USD | 1,986,000USD | 1,538,000USD | 1,746,000USD | 1,808,000USD | 1,709,000USD | 1,923,000USD |
| Total Operating Expenses | 2,343,000USD | 1,910,000USD | 1,986,000USD | 1,525,000USD | 1,735,000USD | 1,804,000USD | 7,574,000USD | 2,259,000USD |
| Operating Income | -910,000USD | -622,000USD | -1,080,000USD | 48,000USD | -116,000USD | -866,000USD | -1,978,000USD | -889,000USD |
| Total Other Income Expense Net | 47,000USD | -248,000USD | -125,000USD | -329,000USD | -383,000USD | -369,000USD | -3,044,000USD | 310,000USD |
| Interest Expense | 301,000USD | 302,000USD | 321,000USD | 392,000USD | 428,000USD | 433,000USD | 429,000USD | 336,000USD |
| Income Before Tax | -863,000USD | -870,000USD | -1,205,000USD | -281,000USD | -499,000USD | -1,235,000USD | -1,942,000USD | -579,000USD |
| Income Tax Expense | 135,000USD | 92,000USD | -197,000USD | 48,000USD | -21,000USD | -323,000USD | — | -169,000USD |
| Net Income | -998,000USD | -612,000USD | -631,000USD | -17,000USD | -280,000USD | -625,000USD | -1,328,000USD | -207,000USD |
| Minority Interest | -484,000USD | 350,000USD | 377,000USD | 312,000USD | 198,000USD | 287,000USD | 563,000USD | 203,000USD |
| Net Income Applicable To Common Shares | -514,000USD | — | -631,000USD | -17,000USD | -280,000USD | -625,000USD | -1,328,000USD | -207,000USD |
| Interest Income | — | 54,000USD | 196,000USD | 63,000USD | 45,000USD | 64,000USD | 36,000USD | 47,000USD |
| Net Interest Income | — | -248,000USD | -125,000USD | -329,000USD | -383,000USD | -369,000USD | -393,000USD | -289,000USD |
| Tax Provision | — | 92,000USD | -197,000USD | 48,000USD | -21,000USD | -323,000USD | -51,000USD | -169,000USD |
| Net Income From Continuing Ops | — | -962,000USD | -1,008,000USD | -329,000USD | -478,000USD | -912,000USD | -1,891,000USD | -410,000USD |
| Ebit | — | -622,000USD | -1,080,000USD | 48,000USD | -116,000USD | -866,000USD | — | -243,000USD |
| Ebitda | — | 672,000USD | 223,000USD | 1,502,000USD | 1,392,000USD | 583,000USD | — | 1,423,000USD |
| Depreciation And Amortization | — | 1,294,000USD | 1,303,000USD | 1,454,000USD | 1,508,000USD | 1,449,000USD | — | 1,666,000USD |
| Reconciled Depreciation | — | 1,294,000USD | 1,303,000USD | 1,454,000USD | 1,508,000USD | 1,449,000USD | 1,673,000USD | 1,644,000USD |
| Unclassified Operating Expenses | — | — | — | — | — | — | 5,865,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 28,082,000USD | 28,340,000USD | 21,325,000USD | 19,746,000USD | 17,628,000USD | 17,837,000USD | 20,605,000USD | 19,714,000USD |
| Cost Of Revenue | 23,039,000USD | 19,155,000USD | 11,981,000USD | 11,364,000USD | 10,902,000USD | 13,371,000USD | 13,685,000USD | 12,228,000USD |
| Gross Profit | 5,043,000USD | 9,185,000USD | 9,344,000USD | 8,382,000USD | 6,726,000USD | 4,466,000USD | 6,920,000USD | 7,486,000USD |
| Selling General Administrative | 7,078,000USD | 7,407,000USD | 6,682,000USD | 5,145,000USD | 4,531,000USD | 4,608,000USD | 4,060,000USD | 3,994,000USD |
| Total Operating Expenses | 7,057,000USD | 11,990,000USD | 9,074,000USD | 5,951,000USD | 5,375,000USD | 13,929,000USD | 4,060,000USD | 3,994,000USD |
| Operating Income | -2,013,999USD | -2,805,000USD | 270,000USD | 2,431,000USD | 1,351,000USD | -9,463,000USD | -4,535,000USD | 1,861,000USD |
| Interest Income | 368,000USD | 248,000USD | 374,000USD | 87,000USD | 3,000USD | 10,000USD | 16,000USD | 220,000USD |
| Interest Expense | 1,574,000USD | 1,499,000USD | 1,112,000USD | 806,000USD | 742,000USD | 1,057,000USD | 1,318,000USD | 1,631,000USD |
| Net Interest Income | -1,206,000USD | -1,251,000USD | -711,000USD | -806,000USD | -739,000USD | -1,047,000USD | -1,302,000USD | -1,433,000USD |
| Income Before Tax | -3,220,000USD | 1,237,000USD | 696,000USD | 2,518,000USD | 947,000USD | -9,453,000USD | 1,558,000USD | 2,081,000USD |
| Income Tax Expense | -493,000USD | -295,000USD | 431,000USD | 963,000USD | 269,000USD | -1,737,000USD | 128,000USD | 451,000USD |
| Tax Provision | -493,000USD | -295,000USD | 426,000USD | 963,000USD | 269,000USD | -1,737,000USD | 128,000USD | 451,000USD |
| Net Income | -1,553,000USD | 2,186,000USD | 610,000USD | 1,328,000USD | 194,000USD | -7,058,000USD | 659,000USD | 1,023,000USD |
| Net Income From Continuing Ops | -2,727,000USD | 1,532,000USD | 401,000USD | 1,555,000USD | 678,000USD | -7,716,000USD | 1,430,000USD | 1,630,000USD |
| Ebit | -2,014,000USD | 2,736,000USD | 1,808,000USD | 3,324,000USD | 1,686,000USD | -8,396,000USD | 2,860,000USD | 3,492,000USD |
| Ebitda | 3,700,000USD | 8,910,000USD | 6,973,000USD | 8,444,000USD | 6,967,000USD | -1,426,000USD | 10,271,000USD | 10,310,000USD |
| Depreciation And Amortization | 5,714,000USD | 6,174,000USD | 5,165,000USD | 5,120,000USD | 5,281,000USD | 6,970,000USD | 7,411,000USD | 6,818,000USD |
| Reconciled Depreciation | 5,714,000USD | 6,174,000USD | 5,100,000USD | 4,783,000USD | 4,972,000USD | 6,970,000USD | 7,411,000USD | 6,818,000USD |
| Total Other Income Expense Net | -1,206,000USD | 4,042,000USD | 426,000USD | 87,000USD | -404,000USD | 10,000USD | 16,000USD | 220,000USD |
| Minority Interest | 1,174,000USD | 654,000USD | 40,000USD | -227,000USD | -484,000USD | -658,000USD | 771,000USD | 5,946,000USD |
| Net Income Applicable To Common Shares | -1,553,000USD | 2,186,000USD | 610,000USD | 1,328,000USD | 194,000USD | -7,058,000USD | 659,000USD | 1,023,000USD |
| Unclassified Operating Expenses | — | 4,583,000USD | 2,392,000USD | — | — | 9,321,000USD | — | — |
| Non Operating Income Net Other | — | — | — | — | — | 10,000USD | 16,000USD | 220,000USD |
| Research Development | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 52,493,000USD | 54,725,000USD | 55,479,000USD | 59,629,000USD | 63,494,000USD | 63,311,000USD | 60,197,000USD | 63,269,000USD |
| Cash And Equivalents | 6,511,000USD | — | 3,462,000USD | 5,095,000USD | 11,081,000USD | 11,241,000USD | 11,025,000USD | 13,827,000USD |
| Total Current Assets | 17,368,000USD | 18,272,000USD | 17,720,000USD | 20,591,000USD | 24,433,000USD | 23,742,000USD | 26,258,000USD | 25,720,000USD |
| Other Current Assets | 830,000USD | 830,000USD | 1,036,000USD | 628,000USD | 1,461,000USD | 1,965,000USD | 250,000USD | 1,952,000USD |
| Other Non Current Assets | 311,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 26,684,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 22,424,000USD | 23,718,000USD | 23,444,000USD | 17,171,000USD | 20,860,000USD | 12,710,000USD | 10,405,000USD | 17,561,000USD |
| Total Stockholder Equity | 23,111,000USD | 23,523,000USD | 24,034,000USD | 24,565,000USD | 24,481,000USD | 24,647,000USD | 25,183,000USD | 26,423,000USD |
| Total Equity Including Noncontrolling Interest | 25,809,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 16,216,000USD | 18,099,000USD | 18,231,000USD | 12,074,000USD | 15,770,000USD | 7,493,000USD | 4,161,000USD | 11,601,000USD |
| Net Receivables | 8,323,000USD | 12,219,000USD | 13,222,000USD | 14,618,000USD | 11,891,000USD | 10,536,000USD | 11,610,000USD | 9,941,000USD |
| Property Plant Equipment Net | 3,571,000USD | 34,784,000USD | 36,075,000USD | 37,340,000USD | 37,343,000USD | 37,810,000USD | 32,159,000USD | 35,793,000USD |
| Goodwill | 1,265,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 78,000USD | 78,000USD | 78,000USD | 78,000USD | 78,000USD | 78,000USD | 78,000USD | 78,000USD |
| Accounts Payable | 582,000USD | 1,081,000USD | 607,000USD | 1,107,000USD | 806,000USD | 1,231,000USD | 1,562,000USD | 1,786,000USD |
| Short Term Debt | 162,000USD | 16,999,000USD | 18,381,000USD | 11,681,000USD | 15,857,000USD | 7,575,000USD | 0USD | 11,836,000USD |
| Common Stock | 10,763,000USD | 10,763,000USD | 10,763,000USD | 10,763,000USD | 10,763,000USD | 10,763,000USD | 10,763,000USD | 10,763,000USD |
| Retained Earnings | 3,136,000USD | 3,650,000USD | 4,262,000USD | 4,893,000USD | 4,910,000USD | 5,190,000USD | 5,815,000USD | 7,143,000USD |
| Total Liab | — | 28,020,000USD | 27,788,000USD | 31,030,000USD | 34,646,000USD | 34,099,000USD | 35,014,000USD | 31,439,000USD |
| Other Current Liab | — | 5,638,000USD | 4,456,000USD | 4,383,000USD | 4,197,000USD | 3,904,000USD | — | 3,939,000USD |
| Capital Stock | — | 10,763,000USD | 10,763,000USD | 10,763,000USD | 10,763,000USD | 10,763,000USD | 10,763,000USD | 10,763,000USD |
| Good Will | — | 1,265,000USD | 1,265,000USD | 1,265,000USD | 1,265,000USD | 1,265,000USD | 1,265,000USD | 1,265,000USD |
| Cash | — | 5,223,000USD | 3,462,000USD | 5,345,000USD | 11,081,000USD | 11,241,000USD | 11,025,000USD | 13,827,000USD |
| Cash And Short Term Investments | — | 5,223,000USD | 3,462,000USD | 5,345,000USD | 11,081,000USD | 11,241,000USD | 11,025,000USD | 13,827,000USD |
| Net Debt | — | 15,963,000USD | 19,148,000USD | 19,271,000USD | 17,638,000USD | 16,799,000USD | 10,477,000USD | 10,327,000USD |
| Short Long Term Debt Total | — | 21,186,000USD | 22,610,000USD | 24,616,000USD | 28,719,000USD | 28,040,000USD | — | 24,154,000USD |
| Property Plant Equipment Gross | — | 76,022,000USD | 76,018,000USD | 79,560,000USD | 78,115,000USD | 80,988,000USD | 73,888,000USD | 81,697,000USD |
| Common Stock Shares Outstanding | — | 6,725,000shares | 6,685,000shares | 6,582,000shares | 6,582,000shares | 6,703,000shares | 6,420,000shares | 6,482,000shares |
| Non Current Assets Total | — | 36,453,000USD | 37,759,000USD | 39,038,000USD | 39,061,000USD | 39,569,000USD | 33,939,000USD | 37,549,000USD |
| Non Current Liabilities Total | — | 4,302,000USD | 4,344,000USD | 13,859,000USD | 13,786,000USD | 21,389,000USD | 19,765,000USD | 13,878,000USD |
| Non Currrent Assets Other | — | 326,000USD | 341,000USD | 355,000USD | 375,000USD | 416,000USD | 437,000USD | 394,000USD |
| Net Working Capital | — | -5,446,000USD | -5,724,000USD | 3,420,000USD | 3,573,000USD | 11,032,000USD | 15,853,000USD | 8,159,000USD |
| Unclassified Current Liabilities | — | -18,099,000USD | -18,231,000USD | -12,074,000USD | -15,770,000USD | -7,493,000USD | 4,682,000USD | -11,601,000USD |
| Unclassified Non Current Liabilities | — | 4,302,000USD | 4,344,000USD | 5,228,000USD | 4,564,000USD | 4,591,000USD | 2,424,000USD | 3,060,000USD |
| Unclassified Equity | — | -1,653,000USD | -1,754,000USD | -1,854,000USD | -1,955,000USD | -2,069,000USD | -2,158,000USD | -2,246,000USD |
| Other Assets | — | — | 341,000USD | 355,000USD | 375,000USD | 416,000USD | 437,000USD | 394,000USD |
| Long Term Debt | — | — | 0USD | 8,631,000USD | 9,222,000USD | 16,798,000USD | 17,341,000USD | 10,818,000USD |
| Unclassified Current Assets | — | — | — | — | — | — | 3,373,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 55,479,000USD | 60,197,000USD | 48,162,000USD | 43,956,000USD | 45,430,000USD | 43,653,000USD | 53,783,000USD | 57,502,000USD |
| Intangible Assets | 78,000USD | 78,000USD | 78,000USD | 78,000USD | 78,000USD | 78,000USD | — | — |
| Other Current Assets | 1,036,000USD | 2,570,000USD | 1,919,000USD | 2,260,000USD | 2,118,000USD | 2,314,000USD | 2,250,000USD | 1,626,000USD |
| Total Liab | 27,788,000USD | 30,170,000USD | 21,883,000USD | 18,331,000USD | 21,191,000USD | 20,003,000USD | 21,972,000USD | 26,454,000USD |
| Total Stockholder Equity | 24,034,000USD | 25,183,000USD | 22,624,000USD | 21,625,000USD | 19,893,000USD | 19,274,000USD | 31,811,000USD | 31,048,000USD |
| Other Current Liab | 4,456,000USD | 4,456,000USD | 2,633,000USD | 2,639,000USD | 2,685,000USD | 3,917,000USD | -283,987,000USD | 2,513,000USD |
| Common Stock | 10,763,000USD | 10,763,000USD | 10,763,000USD | 10,763,000USD | 10,758,000USD | 10,753,000USD | 10,753,000USD | 10,711,000USD |
| Capital Stock | 10,763,000USD | 10,763,000USD | 10,763,000USD | 10,763,000USD | 10,758,000USD | 10,753,000USD | 10,753,000USD | 10,711,000USD |
| Retained Earnings | 4,262,000USD | 5,815,000USD | 3,629,000USD | 3,019,000USD | 1,691,000USD | 1,497,000USD | 8,555,000USD | 7,896,000USD |
| Good Will | 1,265,000USD | 1,265,000USD | 1,265,000USD | 1,265,000USD | 1,265,000USD | 1,265,000USD | — | — |
| Other Assets | 341,000USD | -1,134,000USD | 443,000USD | 87,000USD | 30,343,000USD | 1,042,000USD | 4,670,000USD | 6,944,000USD |
| Cash | 3,462,000USD | 11,025,000USD | 13,690,000USD | 12,335,000USD | 8,145,000USD | 3,961,000USD | 1,429,000USD | 1,442,000USD |
| Cash And Equivalents | 3,462,000USD | 11,025,000USD | 13,690,000USD | 12,335,000USD | 8,145,000USD | 3,961,000USD | 1,429,000USD | 1,442,000USD |
| Cash And Short Term Investments | 3,462,000USD | 11,025,000USD | 13,690,000USD | 12,335,000USD | 8,145,000USD | 3,961,000USD | 1,429,000USD | 1,442,000USD |
| Total Current Assets | 17,720,000USD | 26,258,000USD | 20,456,000USD | 18,723,000USD | 15,087,000USD | 10,850,000USD | 10,742,000USD | 9,946,000USD |
| Total Current Liabilities | 23,444,000USD | 10,405,000USD | 10,779,000USD | 5,175,000USD | 5,891,000USD | 12,380,000USD | 8,214,000USD | 9,474,000USD |
| Net Debt | 19,148,000USD | 12,203,000USD | 3,953,000USD | 1,980,000USD | 9,329,000USD | 10,441,000USD | 14,693,000USD | 18,724,000USD |
| Short Term Debt | 18,381,000USD | 4,387,000USD | 6,602,000USD | 2,051,000USD | 2,792,000USD | 7,407,000USD | 5,514,000USD | 6,526,000USD |
| Short Long Term Debt | 18,231,000USD | 4,161,000USD | 6,545,000USD | 1,759,000USD | 1,081,000USD | 1,157,000USD | 2,001,000USD | 2,119,000USD |
| Short Long Term Debt Total | 22,610,000USD | 23,228,000USD | 17,643,000USD | 14,315,000USD | 17,474,000USD | 14,402,000USD | 16,472,000USD | 20,166,000USD |
| Long Term Debt | 0USD | 17,341,000USD | 11,041,000USD | 12,205,000USD | 14,323,000USD | 3,440,000USD | 1,954,000USD | 3,332,000USD |
| Net Receivables | 13,222,000USD | 12,663,000USD | 4,847,000USD | 4,128,000USD | 4,824,000USD | 4,575,000USD | 7,063,000USD | 6,878,000USD |
| Accounts Payable | 607,000USD | 1,562,000USD | 315,000USD | 230,000USD | 318,000USD | 683,000USD | 557,000USD | 435,000USD |
| Property Plant Equipment Net | 36,075,000USD | 32,159,000USD | 25,920,000USD | 23,803,000USD | 28,927,000USD | 31,323,000USD | 42,586,000USD | 46,694,000USD |
| Property Plant Equipment Gross | 76,018,000USD | 73,888,000USD | 81,303,000USD | 74,573,000USD | 74,624,000USD | 30,418,000USD | 41,480,000USD | 46,694,000USD |
| Common Stock Shares Outstanding | 6,616,000shares | 6,703,000shares | 6,393,000shares | 6,303,000shares | 6,059,000shares | 6,182,000shares | 5,930,000shares | 6,017,647shares |
| Non Current Assets Total | 37,759,000USD | 33,939,000USD | 27,706,000USD | 25,233,000USD | 30,343,000USD | 32,803,000USD | 43,041,000USD | 47,556,000USD |
| Non Current Liabilities Total | 4,344,000USD | 19,765,000USD | 11,104,000USD | 13,156,000USD | 15,300,000USD | 7,623,000USD | 13,758,000USD | 16,980,000USD |
| Non Currrent Assets Other | 341,000USD | 437,000USD | 443,000USD | 87,000USD | 73,000USD | 137,000USD | -2,513,545,000USD | -2,957,138,000USD |
| Net Working Capital | -5,724,000USD | 15,853,000USD | 9,677,000USD | 13,548,000USD | 9,196,000USD | -1,530,000USD | 2,528,000USD | 472,000USD |
| Unclassified Current Liabilities | -18,231,000USD | -4,161,000USD | -5,316,000USD | -1,574,000USD | -140,985,000USD | -210,784,000USD | -285,858,000USD | -384,119,000USD |
| Unclassified Non Current Liabilities | 4,344,000USD | 2,424,000USD | — | -16,205,000USD | — | -3,858,000USD | 6,490,000USD | 6,968,000USD |
| Unclassified Equity | -1,754,000USD | -2,158,000USD | -2,531,000USD | -2,920,000USD | -3,314,000USD | -3,729,000USD | 1,750,000USD | 55,738,000USD |
| Inventory | — | -1,392,000USD | — | 1,245,000USD | 1,174,000USD | 364,000USD | — | 350,000USD |
| Current Deferred Revenue | — | — | -1,226,000USD | 70,000USD | 140,000,000USD | 210,000,000USD | 286,000,000USD | 382,000,000USD |
| Accumulated Other Comprehensive Income | — | — | 0USD | — | 0USD | 0USD | 0USD | -54,008,000USD |
| Other Liab | — | — | — | 17,156,000USD | 618,000USD | 7,623,000USD | 2,800,000USD | 3,340,000USD |
| Net Tangible Assets | — | — | — | 21,625,000USD | 24,239,000USD | 21,696,000USD | 27,146,000USD | 25,102,000USD |
| Unclassified Current Assets | — | — | — | -1,245,000USD | -1,174,000USD | — | — | — |
| Unclassified Non Current Assets | — | — | — | — | -30,343,000USD | -1,042,000USD | -4,215,000USD | -6,082,000USD |
| Deferred Long Term Liab | — | — | — | — | — | 418,000USD | 2,514,000USD | 3,340,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 2,640,000USD |
| Stock Based Compensation | 203,000USD |
| Change To Account Receivables | 2,536,000USD |
| Change To Liabilities | -23,000USD |
| Change In Working Capital | 2,499,000USD |
| Operating Cash Flow | 4,385,000USD |
| Capital Expenditures | -99,000USD |
| Investing Cash Flow | -99,000USD |
| Net Debt Issuance | -1,112,000USD |
| Other Financing Activities | -125,000USD |
| Financing Cash Flow | -1,237,000USD |
| Change In Cash | 3,049,000USD |
| End Cash Flow | 6,761,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -612,000USD | -2,724,994,000USD | -17,000USD | -478,000USD | -625,000USD | 1,532,000USD | -410,000USD | 3,602,000USD |
| Depreciation | 1,294,000USD | 5,709,589,000USD | 1,454,000USD | 1,508,000USD | 1,449,000USD | 6,174,000USD | 1,663,000USD | 1,523,000USD |
| Stock Based Compensation | 101,000USD | 403,696,000USD | 101,000USD | 114,000USD | 89,000USD | 88,000USD | 88,000USD | 99,000USD |
| Other Non Cash Items | -100,000USD | -2,579,611,000USD | -137,000USD | 108,000USD | -132,000USD | 136,000USD | -105,000USD | -3,291,000USD |
| Change To Account Receivables | 1,002,999USD | 1,396,000USD | -2,727,000USD | -1,355,000USD | 2,127,000USD | — | -144,000USD | -1,693,000USD |
| Change In Working Capital | 1,567,000USD | -384,000USD | 371,000USD | -1,624,000USD | 1,722,000USD | -6,946,000USD | -764,000USD | -825,000USD |
| Total Cash From Operating Activities | 2,149,000USD | -704,000USD | 1,671,000USD | -372,000USD | 2,503,000USD | 167,000USD | 472,000USD | 1,286,000USD |
| Capital Expenditures | -41,000USD | 1,984,000USD | -3,702,000USD | -1,901,000USD | -4,015,000USD | -7,938,000USD | -879,000USD | -1,216,000USD |
| Free Cash Flow | 2,108,000USD | 1,280,000USD | -2,031,000USD | -2,273,000USD | -1,512,000USD | -4,386,000USD | -407,000USD | 70,000USD |
| Total Cashflows From Investing Activities | -41,000USD | 1,984,000USD | -3,702,000USD | -1,901,000USD | -4,015,000USD | -7,105,000USD | -704,000USD | -853,000USD |
| Net Borrowings | -472,000USD | -2,913,000USD | -3,934,000USD | 2,113,000USD | 1,720,000USD | 1,356,000USD | -177,000USD | — |
| Total Cash From Financing Activities | -597,000USD | -2,913,000USD | -3,955,000USD | 2,113,000USD | 1,728,000USD | 4,405,000USD | -177,000USD | 1,011,000USD |
| Change In Cash | 1,511,000USD | -1,633,000USD | -5,986,000USD | -160,000USD | 216,000USD | -2,533,000USD | -409,000USD | 1,444,000USD |
| Begin Period Cash Flow | 3,712,000USD | 5,345,000USD | 11,331,000USD | 11,491,000USD | 11,275,000USD | 14,077,000USD | 14,486,000USD | 13,042,000USD |
| End Period Cash Flow | 5,223,000USD | 3,712,000USD | 5,345,000USD | 11,331,000USD | 11,491,000USD | 11,275,000USD | 14,077,000USD | 14,486,000USD |
| Other Cashflows From Financing Activities | -125,000USD | -3,026,886,000USD | -21,000USD | 2,113,000USD | 8,000USD | -221,000USD | -704,000USD | -1USD |
| Other Cashflows From Investing Activities | — | 0USD | — | — | 295,000USD | 833,000USD | 538,000USD | — |
| Unclassified Operating Cash Flow | — | -809,000,000USD | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | — | 3,026,886,000USD | — | -2,113,000USD | — | 3,270,000USD | — | 1,011,001USD |
| Investments | — | — | -3,702,000USD | -1,901,000USD | -4,015,000USD | -4,365,000USD | -704,000USD | -853,000USD |
| Unclassified Investing Cash Flow | — | — | 3,702,000USD | 1,901,000USD | 3,720,000USD | 4,365,000USD | — | 1,216,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 1,532,000USD | 265,000USD | 1,555,000USD | 194,000USD | -7,716,000USD | 1,430,000USD | 1,630,000USD | 2,940,000USD |
| Depreciation | 6,174,000USD | 5,165,000USD | 4,783,000USD | 5,281,000USD | 6,970,000USD | 7,411,000USD | 6,818,000USD | 6,677,000USD |
| Stock Based Compensation | 373,000USD | 389,000USD | 399,000USD | 420,000USD | 299,000USD | 230,000USD | 223,000USD | 323,000USD |
| Other Non Cash Items | -607,000USD | 952,000USD | 450,000USD | 1,585,000USD | 8,537,000USD | 361,000USD | 39,000USD | 707,000USD |
| Change To Account Receivables | -6,939,000,000USD | -719,000USD | 696,000USD | -519,000USD | 2,966,000USD | -1,187,000USD | -420,000USD | -860,000USD |
| Change In Working Capital | -6,946,000USD | -294,000USD | -296,000USD | -853,000USD | 3,817,000USD | -941,000USD | -696,000USD | -1,528,000USD |
| Total Cash From Operating Activities | 167,000USD | 5,718,000USD | 7,235,000USD | 6,267,000USD | 9,745,000USD | 8,047,000USD | 8,062,000USD | 7,853,000USD |
| Capital Expenditures | -7,938,000USD | -6,273,000USD | -388,000USD | -1,674,000USD | -455,000USD | -990,000USD | -1,577,000USD | -803,000USD |
| Free Cash Flow | -7,771,000USD | -555,000USD | 6,847,000USD | 4,593,000USD | 9,290,000USD | 7,057,000USD | 6,485,000USD | 7,050,000USD |
| Investments | -7,105,000USD | -6,232,000USD | -388,000USD | -1,674,000USD | -2,389,000USD | -990,000USD | -1,526,000USD | -653,000USD |
| Total Cashflows From Investing Activities | -7,105,000USD | -6,273,000USD | -388,000USD | -1,674,000USD | -2,389,000USD | -990,000USD | -1,526,000USD | -653,000USD |
| Net Borrowings | 4,626,000USD | 2,121,000USD | -2,032,000USD | 580,000USD | -2,275,000USD | -6,173,000USD | -6,556,000USD | -7,368,000USD |
| Total Cash From Financing Activities | 4,405,000USD | 1,910,000USD | -2,657,000USD | -655,000USD | -4,810,000USD | -7,070,000USD | -7,246,000USD | -7,919,000USD |
| Change In Cash | -2,533,000USD | 1,355,000USD | 4,190,000USD | 3,938,000USD | 2,546,000USD | -13,000USD | -710,000USD | -719,000USD |
| Begin Period Cash Flow | 13,808,000USD | 12,453,000USD | 8,263,000USD | 4,325,000USD | 1,779,000USD | 1,792,000USD | 2,502,000USD | 2,871,000USD |
| End Period Cash Flow | 11,275,000USD | 13,808,000USD | 12,453,000USD | 8,263,000USD | 4,325,000USD | 1,779,000USD | 1,792,000USD | 2,152,000USD |
| Other Cashflows From Investing Activities | 833,000USD | — | — | 0USD | 150,000USD | 0USD | 51,000USD | 150,000USD |
| Other Cashflows From Financing Activities | -221,000USD | -211,000USD | -630,000USD | -914,999USD | -761,000USD | -897,000USD | -690,000USD | -551,000USD |
| Unclassified Investing Cash Flow | 7,105,000USD | 6,232,000USD | — | 1,674,000USD | — | — | 1,526,000USD | — |
| Sale Purchase Of Stock | — | 0USD | 5,000USD | 5,000USD | -761,000USD | -897,000USD | -690,000USD | -551,000USD |
| Change To Liabilities | — | — | 0USD | 851,000USD | 179,000USD | 130,000USD | 115,000USD | 125,000USD |
| Change To Inventory | — | — | — | 519,000,000USD | — | — | — | 0USD |
| Cash And Cash Equivalents Changes | — | — | — | — | 2,546,000USD | -13,000USD | -710,000USD | -719,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | -2,162,000USD | — | — | -1,266,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | -1,013,000USD | — | 1,380,000USD | 1,217,000USD |
| Dividends Paid | — | — | — | — | — | — | -690,000USD | -666,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Patient Income | 4,064,000 | USD | 0001437749-26-017046 |
| Q1 2026Quarterly · 2026-03-31 | Product | Rental Income From Medical Services | 3,020,000 | USD | 0001437749-26-017046 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Direct Patient Services | 4,064,000 | USD | 0001437749-26-017046 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Medical Equipment Leasing | 3,020,000 | USD | 0001437749-26-017046 |
| Q4 2025Quarterly · 2025-12-31 | Product | Patient Income | 4,874,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Rental Income From Medical Services | 2,854,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Direct Patient Services | 4,874,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Medical Equipment Leasing | 2,854,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Equipment Sales | 0 | USD | 0001437749-26-010731 |
| FY 2025Yearly · 2025-12-31 | Product | Patient Income | 15,529,000 | USD | 0001437749-26-010731 |
| FY 2025Yearly · 2025-12-31 | Product | Rental Income From Medical Services | 12,553,000 | USD | 0001437749-26-010731 |
| FY 2025Yearly · 2025-12-31 | Segment | Direct Patient Services | 15,529,000 | USD | 0001437749-26-010731 |
| FY 2025Yearly · 2025-12-31 | Segment | Medical Equipment Leasing | 12,553,000 | USD | 0001437749-26-010731 |
| Q3 2025Quarterly · 2025-09-30 | Product | Patient Income | 4,034,000 | USD | 0001437749-25-035088 |
| Q3 2025Quarterly · 2025-09-30 | Product | Rental Income From Medical Services | 3,137,000 | USD | 0001437749-25-035088 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Direct Patient Services | 4,034,000 | USD | 0001437749-25-035088 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Medical Equipment Leasing | 3,137,000 | USD | 0001437749-25-035088 |
| Q2 2025Quarterly · 2025-06-30 | Product | Patient Income | 3,500,000 | USD | 0001437749-25-026568 |
| Q2 2025Quarterly · 2025-06-30 | Product | Rental Income From Medical Services | 3,571,000 | USD | 0001437749-25-026568 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Direct Patient Services | 3,500,000 | USD | 0001437749-25-026568 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Medical Equipment Leasing | 3,571,000 | USD | 0001437749-25-026568 |
| Q1 2025Quarterly · 2025-03-31 | Product | Patient Income | 3,121,000 | USD | 0001437749-26-017046 |
| Q1 2025Quarterly · 2025-03-31 | Product | Rental Income From Medical Services | 2,991,000 | USD | 0001437749-26-017046 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Direct Patient Services | 3,121,000 | USD | 0001437749-26-017046 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Medical Equipment Leasing | 2,991,000 | USD | 0001437749-26-017046 |
| Q4 2024Quarterly · 2024-12-31 | Product | Patient Income | 4,749,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Rental Income From Medical Services | 4,165,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Direct Patient Services | 4,749,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Medical Equipment Leasing | 4,320,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | Equipment Sales | 155,000 | USD | 0001437749-26-010731 |
| FY 2024Yearly · 2024-12-31 | Product | Patient Income | 12,556,000 | USD | 0001437749-26-010731 |
| FY 2024Yearly · 2024-12-31 | Product | Rental Income From Medical Services | 15,629,000 | USD | 0001437749-26-010731 |
| FY 2024Yearly · 2024-12-31 | Segment | Direct Patient Services | 12,556,000 | USD | 0001437749-26-010731 |
| FY 2024Yearly · 2024-12-31 | Segment | Medical Equipment Leasing | 15,784,000 | USD | 0001437749-26-010731 |
| Q3 2024Quarterly · 2024-09-30 | Product | Equipment Sales | 0 | USD | 0001437749-24-035251 |
| Q3 2024Quarterly · 2024-09-30 | Product | Patient Income | 3,687,000 | USD | 0001437749-24-035251 |
| Q3 2024Quarterly · 2024-09-30 | Product | Rental Income From Medical Services | 3,312,000 | USD | 0001437749-24-035251 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Direct Patient Services | 3,687,000 | USD | 0001437749-25-035088 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Medical Equipment Leasing | 3,312,000 | USD | 0001437749-25-035088 |
| Q2 2024Quarterly · 2024-06-30 | Product | Patient Income | 3,157,000 | USD | 0001437749-25-026568 |
| Q2 2024Quarterly · 2024-06-30 | Product | Rental Income From Medical Services | 3,899,000 | USD | 0001437749-25-026568 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Direct Patient Services | 3,157,000 | USD | 0001437749-25-026568 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Medical Equipment Leasing | 3,899,000 | USD | 0001437749-25-026568 |
| FY 2023Yearly · 2023-12-31 | Product | Equipment Sales | 200,000 | USD | 0001437749-25-011052 |
| FY 2023Yearly · 2023-12-31 | Product | Patient Income | 3,353,000 | USD | 0001437749-25-011052 |
| FY 2023Yearly · 2023-12-31 | Product | Rental Income From Medical Services | 17,772,000 | USD | 0001437749-25-011052 |
| FY 2023Yearly · 2023-12-31 | Segment | Direct Patient Services | 3,553,000 | USD | 0001437749-25-011052 |
| FY 2023Yearly · 2023-12-31 | Segment | Medical Equipment Leasing | 17,772,000 | USD | 0001437749-25-011052 |
| FY 2022Yearly · 2022-12-31 | Product | Equipment Sales | 0 | USD | 0001437749-24-010308 |
| FY 2022Yearly · 2022-12-31 | Product | Patient Income | 3,091,000 | USD | 0001437749-24-010308 |
| FY 2022Yearly · 2022-12-31 | Product | Rental Income From Medical Services | 16,655,000 | USD | 0001437749-24-010308 |
| FY 2022Yearly · 2022-12-31 | Segment | Direct Patient Services | 3,091,000 | USD | 0001437749-24-010308 |
| FY 2022Yearly · 2022-12-31 | Segment | Medical Equipment Leasing | 16,655,000 | USD | 0001437749-24-010308 |
| FY 2021Yearly · 2021-12-31 | Product | Patient Income | 2,909,000 | USD | 0001437749-23-008796 |
| FY 2021Yearly · 2021-12-31 | Product | Rental Income From Medical Services | 14,719,000 | USD | 0001437749-23-008796 |
| FY 2021Yearly · 2021-12-31 | Segment | Domestic | 14,719,000 | USD | 0001437749-23-008796 |
| FY 2021Yearly · 2021-12-31 | Segment | Foreign | 2,909,000 | USD | 0001437749-23-008796 |
| Q1 2021Quarterly · 2021-03-31 | Geography | Domestic | 3,699,000 | USD | 0000744825-21-000054 |
| Q1 2021Quarterly · 2021-03-31 | Geography | Foreign | 665,000 | USD | 0000744825-21-000054 |
| FY 2020Yearly · 2020-12-31 | Product | Patient Income | 1,633,000 | USD | 0001437749-22-007687 |
| FY 2020Yearly · 2020-12-31 | Product | Rental Income From Medical Services | 16,204,000 | USD | 0001437749-22-007687 |
| FY 2020Yearly · 2020-12-31 | Segment | Domestic | 16,204,000 | USD | 0001437749-22-007687 |
| FY 2020Yearly · 2020-12-31 | Segment | Foreign | 1,633,000 | USD | 0001437749-22-007687 |
| FY 2020Yearly · 2020-12-31 | Geography | Domestic | 16,204,000 | USD | 0000744825-21-000030 |
| FY 2020Yearly · 2020-12-31 | Geography | Foreign | 1,633,000 | USD | 0000744825-21-000030 |
| FY 2019Yearly · 2019-12-31 | Geography | Domestic | 19,396,000 | USD | 0000744825-21-000030 |
| FY 2019Yearly · 2019-12-31 | Geography | Foreign | 1,209,000 | USD | 0000744825-21-000030 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.